US Map / Kentucky
State KY

Clinical Trials in Kentucky

Kentucky is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kentucky and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 140 actively recruiting studies with Kentucky sites out of 140 registered in total. The busiest research areas in Kentucky are Non-Small Cell Lung Cancer, Colorectal Cancer, Ulcerative Colitis. Leading sponsors running trials in the state include University of Louisville, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Kentucky trials break down as Phase 1 (20), Phase 2 (36), Phase 3 (42), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
140
Recruiting Now
140
← Back to US Map
Top Conditions in Kentucky
Non-Small Cell Lung Cancer (3)Colorectal Cancer (3)Ulcerative Colitis (3)Hidradenitis Suppurativa (HS) (2)Multiple Myeloma (2)Asthma (2)Head and Neck Cancer (2)Esophageal Cancer (2)Large B-cell Lymphoma (2)Cancer (2)NSCLC (2)Stroke (2)

Frequently Asked Questions — Clinical Trials in Kentucky

How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 140 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 140. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Non-Small Cell Lung Cancer, Colorectal Cancer, Ulcerative Colitis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Kentucky

NCT07202988 N/A
Recruiting
Tasting Plant Forward Meals
Condition
Dietary Exposure
Enrollment
80 pts
Location
United States
Sponsor
Sara Maksi
View Trial →
NCT06001827 N/A
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Condition
Chronic Kidney Diseases
Enrollment
600 pts
Location
United States
Sponsor
VenoStent
View Trial →
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06860594 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Th...
Condition
Astrocytoma, IDH-Mutant, Grade 2
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06850805 Phase 3
Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adole...
Condition
Chronic Rhinosinusitis Without Nasal Polyps
Enrollment
84 pts
Location
United States
Sponsor
Optinose US Inc.
View Trial →
NCT06408259 Phase 3
Recruiting
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimo...
Condition
Multiple Sclerosis, Relapsing-Remitting
Enrollment
194 pts
Location
United States, Australia, Italy
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03876288 N/A
Recruiting
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Condition
Gastroparesis
Enrollment
3,000 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT06208605 N/A
Recruiting
Innovations in Personalizing Treatment Study
Condition
Eating Disorders
Enrollment
320 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT04165070 Phase 1, Phase 2
Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) ...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
450 pts
Location
United States, Canada, Hungary
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06423911 Phase 3
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Condition
Chronic Myeloid Leukemia
Enrollment
333 pts
Location
United States, Australia, Belgium
Sponsor
Ascentage Pharma Group Inc.
View Trial →
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
View Trial →
NCT06024304 N/A
Recruiting
InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following F...
Condition
Fracture of Hip
Enrollment
30 pts
Location
United States
Sponsor
Paul E. Matuszewski
View Trial →
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05550298 N/A
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infectio...
Condition
Hematopoietic Cell Transplant
Enrollment
2,000 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06419374 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With...
Condition
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT05270213 Phase 1
Recruiting
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
164 pts
Location
United States
Sponsor
Riboscience, LLC.
View Trial →
Page 4 of 6 — 140 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology